Areas of Application
The panel is designed for personalized
monitoring of tumor, adjustment
of treatment regimens and improvement
of the life quality of cancer patients
Specifi cation
The method is based on a new class
of highly sensitive, tissue-specifi c
epigenetic tumor markers - miRNAs
and analysis of their dependence
on and correlation with characteristics
of molecular tumor profi le
Advantages
Impo rtant advantages of miRNAs over
other biomarkers are their stability, selectivity,
and specifi city to a particular type of cancer.
The microRNA analysis provides
comprehensive information about tumors
(risk of recurrence, degree of malignancy,
sensitivity to chemotherapy, hormone therapy,
and radiotherapy, etc.). The proposed panel
of biomarkers is informative,
highly sensitive, and enables time saving
Stage of Development.
Suggestion for Commercialization
IRL5, TRL6
Personalized monitoring with the use
of proposed tumor biomarker panel,
upon request
IPR Protection
IPR1, IPR3
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"